Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study

Published:2021-07-23 Issue:8 Volume:7 Page:e736
ISSN:2373-8731
Container-title:Transplantation Direct
language:en
Short-container-title:

Author:

Lam Ngan N.,Jeong Rachel,Quinn Robert R.,Ravani Pietro,Xiao Huiling,McAdams-DeMarco Mara,Axelrod David A.,Schnitzler Mark A.,Snyder Jon J.,Lentine Krista L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference25 articles.

1. KDIGO clinical practice guideline for the care of kidney transplant recipients.;Am J Transplant,2009

2. Interleukin 2 receptor antagonists for kidney transplant recipients.;Webster;Cochrane Database Syst Rev,2010

3. Incidence, risk factors, and outcomes of kidney transplant recipients treated with both basiliximab and antithymocyte globulin.;Jeong;Can J Kidney Health Dis,2020

4. Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice.;Dharnidharka;Transpl Int,2018

5. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.;Brennan;N Engl J Med,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Induction Therapy on Graft Functions in Terms of Immunologic Risk;Transplantation Proceedings;2023-09

2. Porcine anti-human lymphocyte immunoglobulin depletes the lymphocyte population to promote successful kidney transplantation;Frontiers in Immunology;2023-03-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP